WebAug 10, 2024 · Gemini Therapeutics is a clinical-stage precision medicine company previously focused on developing novel therapeutic compounds to treat genetically … WebOct 5, 2024 · Gemini will concentrate its resources to advance GEM103 for the treatment of genetically defined age-related macular degeneration (AMD). GEM103 has the potential …
Gemini Therapeutics and Disc Medicine Announce Merger …
WebAug 10, 2024 · Gemini Therapeutics, Inc. Brian Piekos Gemini Therapeutics, Inc. (617) 401-4400 [email protected] Disc Medicine, Inc. Peg Rusconi (Media) Verge … WebAug 12, 2024 · CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Gemini Therapeutics (Nasdaq: GMTX), a clinical stage precision medicine company developing innovative treatments for genetically-defined age-related macular degeneration (AMD), today reported its financial results for the second quarter ended June 30, 2024 and provided a business … hearing aid cup
8-K - SEC
WebOct 5, 2024 · Gemini will concentrate its resources to advance GEM103 for the treatment of genetically defined age-related macular degeneration (AMD). GEM103 has the potential to be a best-in-class complement regulator for the treatment of GA,” said Jason Meyenburg, Chief Executive Officer of Gemini Therapeutics, Inc. WebNov 13, 2024 · CAMBRIDGE, Mass. & SAN FRANCISCO--(BUSINESS WIRE)-- Gemini Therapeutics, a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD), today announced that the Phase 1 study of GEM103, the Company’s investigational treatment … WebNov 12, 2024 · Gemini Therapeutics, Inc. today announced that Raj Maturi, M.D., will present a poster at the 2024 Annual Meeting of the American Academy of … mountaineer vision center morgantown wv